ONC Insider Trading

Insider Ownership Percentage: 7.43%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $295,198,300.30

Beigene Insider Trading History Chart

This chart shows the insider buying and selling history at Beigene by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$25MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$200M-$100M$0$100M$200MTotal Insider BuyingTotal Insider Selling

Beigene Share Price & Price History

Current Price: $230.98
Price Change: Price Increase of +2.84 (1.24%)
As of 04/17/2025 05:00 PM ET

This chart shows the closing price history over time for ONC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMarApr$230.98Closing price on 04/17/25:

SEC Filings (Institutional Ownership Changes) for Beigene (NASDAQ:ONC)

48.55% of Beigene stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Beigene logo
BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.
Read More on Beigene

Today's Range

Now: $230.98
Low: $227.40
High: $234.15

50 Day Range

MA: $245.97
Low: $206.32
High: $278.38

52 Week Range

Now: $230.98
Low: $126.97
High: $287.88

Volume

519,865 shs

Average Volume

491,582 shs

Market Capitalization

$22.79 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.49

Who are the company insiders with the largest holdings of Beigene?

Beigene's top insider shareholders include:
  1. Xiaodong Wang (Insider)
  2. Lai Wang (Insider)
  3. Bros Advisors Lp Baker (Director)
  4. Chan Henry Lee (SVP)
  5. John Oyler (CEO)
  6. Xiaobin Wu (COO)
Learn More about top insider investors at Beigene.